Results 181 to 190 of about 39,565,656 (306)

Biased agonists differentially modulate the receptor conformation ensembles in Angiotensin II type 1 receptor. [PDF]

J Mol Graph Model, 2023
Nivedha AK, Lee S, Vaidehi N.
europepmc   +1 more source

Inhibitory Effect of Trilinolein on Angiotensin Ii-Induced Cardiomyocyte Hypertrophy

, 2009
The myocardial protective effects of trilinolein, isolated from the Chinese herb Sanchi (Panax notoginseng), may be related to its antioxidant effects.
LEE, HORNG-MO;LEE, WEN-SEN;SHIH, NENG- LANG;CHEN, JIN-JER;CHAN, PAUL, 李宏謀;李文森;施能明;陳錦澤;陳保羅   +1 more
core  

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Angiotensin II type 1 receptor signaling promotes bladder cancer progression and its inhibition by Losartan. [PDF]

Hypertens Res
Yamanaka R, Miura K, Yamasaki N, Ogata S, Nakamura M, Inaba T, Bold-Erdene A, Enkhbaatar U, Mirkatouli FB, Miura S, Hosomi N, Kobatake K, Takemoto K, Kohada Y, Tasaka R, Hatayama T, Yukihiro K, Shikuma H, Iwane K, Hinata N, Kaminuma O.   +20 more
europepmc   +1 more source

Development of a Non-Peptide Angiotensin II Type 1 Receptor Ligand by Structural Modification of Olmesartan as a Biased Agonist. [PDF]

Biomedicines, 2023
Matsuo Y, Suematsu Y, Morita H, Miura SI.   +3 more
europepmc   +1 more source

Angiotensin II Type 1 Receptor Blockers

Circulation, 2001
M. Burnier
semanticscholar   +1 more source

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

MicroRNA-155 mediates endogenous angiotensin II type 1 receptor regulation: implications for innovative type 2 diabetes mellitus management. [PDF]

World J Diabetes, 2023
Papadopoulos KI, Papadopoulou A, Aw TC.
europepmc   +1 more source

Angiotensin‐II type 1 receptor interaction is a major regulator for liver fibrosis development in rats

Hepatology, 2001
H. Yoshiji, S. Kuriyama, J. Yoshii, Y. Ikenaka, R. Noguchi, T. Nakatani, H. Tsujinoue, H. Fukui   +7 more
semanticscholar   +1 more source

A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum

ESC Heart Failure, Volume 12, Issue 2, Page 1132-1140, April 2025.
Abstract The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece.
Christina Chrysohoou, Maria Marketou, Maria Aktsiali, Ioannis Griveas   +3 more
wiley   +1 more source